Dr. Andrade is a physician scientist with a focus on human immunology. Dr. Andrade studies diagnostic and prognostic biomarkers associated with the pathogenesis of infectious diseases of great relevance to public health. Graduated from the Federal University of Bahia (UFBA), with a doctorate in Human Pathology from the Oswaldo Cruz Foundation and post-doctorate from the National Institute of Allergy and Infectious Diseases, National Institutes of Health. He is currently a researcher at the Gonçalo Moniz Institute, Oswaldo Cruz Foundation, in Salvador, Bahia, as well as a professor of Medicine at UniFTC, UNIFACS and also at the post-graduation program at the Bahiana School of Medicine and Public Health (EBMSP). He coordinates a multinational group of translational medicine that merges experimental and clinical data to describe inflammatory pathways involved in the immunopathogenesis of diseases such as tuberculosis, HIV, viral hepatitis, arboviruses, malaria, leishmaniasis and bacterial pneumonia. He leads a collaborative network of laboratories in South Africa (University of Cape Town), India (National Institute for Research in Tuberculosis), China (Henan Chest Hospital) and the United States (Vanderbilt University Medical Center and Johns Hopkins University School of Medicine), from where he develops studies to validate the results in places with different epidemiological profiles. Since 2019, he is the Co-Principal Investigator of the Regional Prospective Observational Research for Tuberculosis (RePORT) International consortium and the Principal Investigator of this consortium in Brazil (RePORT Brasil). He is a member of the National Academy of Medicine (Young Leadership category), of the Interacademy Medical Panel (Germany), of the Royal Society of Medicine (England), in addition to being a permanent member of the Collaboration for TB Vaccine Discovery (CTVD, Gates Foundation). He is Chief Editor of the journal Frontiers in Tropical Diseases. He was Associate Editor of the journal BMC Infectious Diseases and is a regular reviewer of journals such as New England Journal of Medicine, JAMA, Science Translational Medicine, Nature Medicine and Lancet. He is also a reviewer and consultant for the Wellcome Trust (England), Francis Crick Institute (England) and the World Health Organization. He has extensive experience in projects with international funding via the National Institutes of Health, Wellcome Trust, Gates Foundation, United Nations and World Health Organization.
Médico pesquisador com foco em imunologia humana. Estuda biomarcadores diagnósticos e prognósticos associados a patogênese de doenças infecciosas de grande relevância para saúde pública. Formado da Universidade Federal da Bahia (UFBA), com doutorado em Patologia Humana pela Fundação Oswaldo Cruz e pós-doutorado no National Institute of Allergy and Infectious Diseases, National Institutes of Health. Atualmente, é pesquisador do Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, em Salvador, Bahia, além de professor de cursos de Medicina na UniFTC, UNIFACS e da pós-graduação da Escola Bahiana de Medicina e Saúde Pública (EBMSP). Coordena um grupo multinacional de medicina translacional que mescla dados experimentais e clínicos para descrever vias inflamatórias envolvidas na imunopatogênese de doenças como tuberculose, HIV, hepatites virais, arboviroses, malária, leishmaniose e pneumonia bacteriana. Lidera uma rede colaborativa de laboratórios na África do Sul (University of Cape Town), Índia (National Institute for Research in Tuberculosis), China (Henan Chest Hospital) e Estados Unidos (Vanderbilt University Medical Center e Johns Hopkins University School of Medicine), de onde desenvolve estudos para validação dos resultados em locais com perfis epidemiológicos distintos. Desde 2019, é co-investigador principal do consórcio Regional Prospective Observational Research for Tuberculosis (RePORT) International e o investigador principal deste consórcio no Brasil (RePORT Brasil). É membro da Academia Nacional de Medicina (categoria Jovem Liderança), da Interacademy Medical Panel (Alemanha), da Royal Society of Medicine (Inglaterra), além de ser membro permanente da Collaboration for TB Vaccine Discovery (CTVD, Gates Foundation). É Section Chief Editor do periódico Frontiers in Tropical Diseases, foi Editor Associado do periódico BMC Infectious Diseases e é revisor regular de revistas como New England Journal of Medicine, Science Translational Medicine, JAMA, Nature Medicine e Lancet. Também é revisor e consultor da Wellcome Trust (Inglaterra), do Francis Crick Institute (Inglaterra) e da Organização Mundial da Saúde. Tem larga experiência em projetos com financiamento internacional via National Institutes of Health, Wellcome Trust, Gates Foundation, Organização das Nações Unidas (ONU) e Organização Mundial da Saúde (OMS).
